MedTrace Logo

Special Survey of Production of Insulin Aspart Specific Antibody

NCT01487369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 204

Last updated 2016-03-04

No results posted yet for this study

Summary

This study is conducted in Japan. The aim of this study is to collect data of production of insulin aspart specific antibody under normal clinical practice conditions.

Conditions

  • Diabetes
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2

Interventions

DRUG

insulin aspart

Injected subcutaneously (s.c., under the skin). Prescribed by physician as a result of normal clinical practice.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-04-30
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01487369 on ClinicalTrials.gov